SARS‐CoV‐2 variants and vulnerability at the global level

VP Chavda, AB Patel… - Journal of medical …, 2022 - Wiley Online Library
Numerous variants of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
pandemic have evolved. Viral variants may evolve with harmful susceptibility to the immunity …

Coronaviruses pathogenesis, comorbidities and multi-organ damage–A review

K Renu, PL Prasanna, AV Gopalakrishnan - Life sciences, 2020 - Elsevier
Abstract Human coronaviruses, especially COVID-19, is an emerging pandemic infectious
disease with high morbidity and mortality. Coronaviruses are associated with comorbidities …

Coronavirus disease 2019–COVID-19

K Dhama, S Khan, R Tiwari, S Sircar… - Clinical microbiology …, 2020 - Am Soc Microbiol
In recent decades, several new diseases have emerged in different geographical areas, with
pathogens including Ebola virus, Zika virus, Nipah virus, and coronaviruses (CoVs) …

[HTML][HTML] Effect of COVID-19 related lockdown on ophthalmic practice and patient care in India: Results of a survey

AG Nair, RA Gandhi, S Natarajan - Indian journal of …, 2020 - journals.lww.com
Purpose: In early 2020, the World Health Organization declared the outbreak of the disease
COVID-19, caused by a new variant of coronavirus 2019-nCoV as a global pandemic. The …

[HTML][HTML] Plants metabolites: possibility of natural therapeutics against the COVID-19 pandemic

FR Bhuiyan, S Howlader, T Raihan, M Hasan - Frontiers in medicine, 2020 - frontiersin.org
COVID-19, a disease induced by SARS-CoV-2 (Severe Acute Respiratory Syndrome
Coronavirus-2), has been the cause of a worldwide pandemic. Though extensive research …

[HTML][HTML] Investigation of Some Antiviral N-Heterocycles as COVID 19 Drug: Molecular Docking and DFT Calculations

M Hagar, HA Ahmed, G Aljohani… - International Journal of …, 2020 - mdpi.com
The novel coronavirus, COVID-19, caused by SARS-CoV-2, is a global health pandemic that
started in December 2019. The effective drug target among coronaviruses is the main …

[HTML][HTML] Fast-track development of vaccines for SARS-CoV-2: the shots that saved the world

VP Chavda, Q Yao, LK Vora, V Apostolopoulos… - Frontiers in …, 2022 - frontiersin.org
In December 2019, an outbreak emerged of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) which leads to coronavirus disease 2019 (COVID-19). The World Health …

Utilizing drug repurposing against COVID-19–efficacy, limitations, and challenges

V Parvathaneni, V Gupta - Life sciences, 2020 - Elsevier
The recent outbreak of Coronavirus disease (COVID-19), first in Eastern Asia and then
essentially across the world has been declared a pandemic by the WHO. COVID-19 is …

[HTML][HTML] Development of electromobility in european union countries under covid-19 conditions

T Rokicki, P Bórawski, A Bełdycka-Bórawska, A Żak… - Energies, 2021 - mdpi.com
The introduction of electromobility contributes to an increase in energy efficiency and lower
air pollution. European countries have not been among the world's leading countries in this …

[HTML][HTML] Overview of current adipose-derived stem cell (ADSCs) processing involved in therapeutic advancements: flow chart and regulation updates before and after …

L Mazini, M Ezzoubi, G Malka - Stem cell research & therapy, 2021 - Springer
Adipose-derived stem cells (ADSCs) have raised big interest in therapeutic applications in
regenerative medicine and appear to fulfill the criteria for a successful cell therapy. Their low …